Advertisement

Topics

Apellis announces initial public offering pricing

11:00 EST 9 Nov 2017 | Healio

Apellis Pharmaceuticals announced it will offer 10.7 million shares of common stock at an initial public offering price of $14 per share, for total gross proceeds of $150 million, according to a company press release.
Underwriters will have a 30-day option to purchase up to 1.607 million additional shares of stock at the public offering price to cover over-allotments.
The offering is expected to close on Nov. 13.

Original Article: Apellis announces initial public offering pricing

NEXT ARTICLE

More From BioPortfolio on "Apellis announces initial public offering pricing"

Advertisement
Quick Search
Advertisement
Advertisement